Sarep­ta CEO Doug In­gram scored a chart-top­ping $57M com­pen­sa­tion deal in 2017. Earn­ing it won’t be easy

Last sum­mer, when ex-Al­ler­gan pres­i­dent Doug In­gram was re­cruit­ed for the top job at Sarep­ta $SRPT, the board set some big goals for the new CEO. And they put up some ex­tra­or­di­nar­i­ly big re­wards if he achieves them.

In­gram’s to­tal com­pen­sa­tion pack­age for the sec­ond half stretch when he was at the helm is worth $56,866,241 — far out­strip­ping any oth­er pay deal out­lined in bio­phar­ma for 2017. There’s about $11 mil­lion in stock awards. The li­on’s share — $44 mil­lion — is in stock op­tions. If he achieves his mis­sion in build­ing the com­pa­ny, and his stock vests, he would end up with as much as 6.6% of the com­pa­ny. Falling short, though, would push that down to as lit­tle as noth­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER